These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8657614)

  • 21. Clinical implications of antibiotic-induced endotoxin release in septic shock.
    Lepper PM; Held TK; Schneider EM; Bölke E; Gerlach H; Trautmann M
    Intensive Care Med; 2002 Jul; 28(7):824-33. PubMed ID: 12122518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
    Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
    J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock].
    Pedersen MØ; Pedersen DS; Pedersen M; Penkowa M
    Ugeskr Laeger; 2008 Feb; 170(6):421-6. PubMed ID: 18252172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria.
    Roger T; Glauser MP; Calandra T
    J Endotoxin Res; 2001; 7(6):456-60. PubMed ID: 11753217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.
    Lamping N; Dettmer R; Schröder NW; Pfeil D; Hallatschek W; Burger R; Schumann RR
    J Clin Invest; 1998 May; 101(10):2065-71. PubMed ID: 9593762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.
    Mitov IG; Terziiski DG
    Infection; 1991; 19(6):383-90. PubMed ID: 1816107
    [No Abstract]   [Full Text] [Related]  

  • 27. Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits.
    Cox AD; Zou W; Gidney MA; Lacelle S; Plested JS; Makepeace K; Wright JC; Coull PA; Moxon ER; Richards JC
    Vaccine; 2005 Oct; 23(43):5045-54. PubMed ID: 16046037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bovine dialyzable leukocyte extract protects against LPS-induced, murine endotoxic shock.
    Franco-Molina MA; Mendoza-Gamboa E; Castillo-León L; Tamez-Guerra RS; Rodríguez-Padilla C
    Int Immunopharmacol; 2004 Dec; 4(13):1577-86. PubMed ID: 15454111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The novel lipopolysaccharide-binding protein CRISPLD2 is a critical serum protein to regulate endotoxin function.
    Wang ZQ; Xing WM; Fan HH; Wang KS; Zhang HK; Wang QW; Qi J; Yang HM; Yang J; Ren YN; Cui SJ; Zhang X; Liu F; Lin DH; Wang WH; Hoffmann MK; Han ZG
    J Immunol; 2009 Nov; 183(10):6646-56. PubMed ID: 19864597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Induction of early endotoxin tolerance with atoxic endotoxin--a new method for preventing sepsis syndrome].
    Staubach KH; Weber H; Brade H; Bruch HP
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1067-70. PubMed ID: 9931792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal anti-endotoxin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Baumgartner JD
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):711-6. PubMed ID: 2261915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationale for the development of immunotherapy regimens against enterococcal infections.
    Theilacker C; Krueger WA; Kropec A; Huebner J
    Vaccine; 2004 Dec; 22 Suppl 1():S31-8. PubMed ID: 15576199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bacterial endotoxins and their effects].
    Bertók L
    Orv Hetil; 1998 Aug; 139(33):1947-53. PubMed ID: 9734211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock.
    Opal SM; Scannon PJ; Vincent JL; White M; Carroll SF; Palardy JE; Parejo NA; Pribble JP; Lemke JH
    J Infect Dis; 1999 Nov; 180(5):1584-9. PubMed ID: 10515819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards a rational development of anti-endotoxin agents: novel approaches to sequestration of bacterial endotoxins with small molecules.
    David SA
    J Mol Recognit; 2001; 14(6):370-87. PubMed ID: 11757070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Early endotoxin tolerance--a preventive concept against infection].
    Staubach KH; Jonas S; Kooistra A; Bruch HP
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():360-3. PubMed ID: 9101876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal administration of a detoxified endotoxin vaccine protects mice against heterologous Gram-negative bacterial pneumonia.
    Chen WH; Kang TJ; Bhattacharjee AK; Cross AS
    Innate Immun; 2008 Oct; 14(5):269-78. PubMed ID: 18809651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective capacity of polyclonal and monoclonal antibodies directed against endotoxin during experimental sepsis.
    Dunn DL; Priest BP; Condie RM
    Arch Surg; 1988 Nov; 123(11):1389-93. PubMed ID: 3178488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Jennerian approach to gram-negative bacillary bacteremia?
    Sanford JP
    N Engl J Med; 1972 Aug; 287(6):304-5. PubMed ID: 5038959
    [No Abstract]   [Full Text] [Related]  

  • 40. Host-parasite interaction in serious infections due to gram-negative bacteria.
    Schellekens JF; Kalter ES; Vreede RW; Verhoef J
    Antonie Van Leeuwenhoek; 1984; 50(5-6):701-10. PubMed ID: 6397137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.